Novel monoclonal antibody targets resolution of chronic inflammation through a differentiated therapeutic strategy...
The Spur Stent System was granted FDA De Novo clearance in a high-risk, long-lesion population...
Medivive’s NAD⁺ therapy is designed to improve bioavailability compared to oral precursors ...
Seal Shield's complete UV-C solution suite is designed to address the full spectrum of device sanitisation needs in clinical environments...
Virica and FUJIFILM Biosciences will co-develop an off-the-shelf enhancer–media solution to boost AAV yields and process robustness in FUJIFILM Biosciences BalanCD HEK293 system...
The conversation explores how this innovation is shaping the future of dermatologic oncology, where real-time imaging, AI-driven insights, and patient-centric care models converge to deliver more effective and accessible cancer treatment...
This partnership is designed to remove that bottleneck by combining Pillar's portfolio of oncoReveal NGS-based kitted panels with CellCarta's global clinical trial testing execution...
The MediSplit program provides eligible MedOne members with complimentary Nanodroppers when filling select ophthalmic prescriptions...
Soundable Health has developed proprietary AI models that analyse acoustic signals generated by the human body to monitor health conditions...
A global randomised trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone...
